Trading Signals: LGND Stock Price Prediction and Forecast (Mon. Aug. 10, 2015 - Wed. Sep. 27, 2023)(Ligand Pharmaceuticals Inc)
| LGND latest price $109.2950 (0.77%) ($109.2950 - $109.2950) on Thu. Mar. 17, 2022. | |
| | Trend Analysis and Forecast | | | Average Daily Percentage Swing | 3.59% (three month average) | RSI | 60 | Latest Price | $109.2950(0.77%) | Stocks Behave Similarly | Similar Stock List | Daily Trend | LGND advances 0.2% a day on average for past five trading days. | Weekly Trend | LGND advances 2.4% a week on average for past two weeks. | Market Behavior | Broad based rally for large cap. Broad based rally for small cap. | Correlated ETFs | Broad market will support LGND advance at 0% a week (0% probability) IBB(61%) IWO(61%) IWM(60%) IWC(57%) IWN(57%) | Factors Impacting LGND price | LGND will decline at least -1.795% in a week (0% probabilities). VIXM(-26%) UUP(-21%) VXX(-17%) TBT(-6%) UNG(-5%) | Explanation | The rally is not sustainable and not supported by the broad market. | | | | | Relative Volatility | (options are extremely cheap) | | | Market Trend Strength | -1.795% (StdDev 3.59%) | Hourly BBV | 1.1 () | Intraday Trend | 0% | | | |
|
5 Day Moving Average | $105.29(3.8%) | 10 Day Moving Average | $103.69(5.41%) | 20 Day Moving Average | $102.64(6.48%) | To recent high | -32.9% | To recent low | 14.6% | Market Cap | $1.756b | | | | Ligand Pharmaceuticals, Inc. is a biopharmaceutical company, which engages in the development and acquisition of technologies that help pharmaceutical companies to discover and develop medicines. Its products include evomela, IV voriconazole, duavee, viviant/conbriza, nexterone, and noxafil-IV. The company was founded by Ronald M. Evans in 1987 and is headquartered in San Diego, CA. |